ARCHIVES

Trastuzumab Showed Improved Survival In Stage IV Breast Cancer with CNS Metastases

This article is from The Cancer Letter archive.

Vol. 34 No. 8 | August 26, 2011

Download PDF Visit The Full Archive

Related Articles

Senate Approves Supplemental Funds For NIH and FDA.

May 23, 2008

ODAC Recommends Femara Campath For FDA Approval.

January 5, 2001

NCI Prepares For Intramural Program Review

June 27, 2014

After A One-Month Retirement, Becker Returns To M.D. Anderson As Research Prof.

November 30, 2001

Stimulus Bill Gives NIH A $10 Billion Boost Over Two Years, Puts Pressure On Institutes to Make Rapid Funding Decisions

February 13, 2009

DCE Advisors approver New Grant Programs In Ovarian Cancer, Biostatistics, Biotech Transfer; Support Services Recompetitions

June 19, 1992